Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Eton Pharmaceutcials Inc (ETON)

Eton Pharmaceutcials Inc (ETON)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 189,757
  • Shares Outstanding, K 20,956
  • Annual Sales, $ 960 K
  • Annual Income, $ -18,320 K
  • 60-Month Beta 1.37
  • Price/Sales 370.72
  • Price/Cash Flow N/A
  • Price/Book 24.20

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.26
  • Number of Estimates 2
  • High Estimate -0.20
  • Low Estimate -0.32
  • Prior Year -0.28
  • Growth Rate Est. (year over year) +7.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.54 +38.47%
on 08/25/20
9.12 -0.71%
on 09/18/20
+1.69 (+22.86%)
since 08/18/20
3-Month
4.80 +88.65%
on 07/14/20
9.12 -0.71%
on 09/18/20
+3.25 (+55.85%)
since 06/18/20
52-Week
2.50 +262.20%
on 03/18/20
9.12 -0.71%
on 09/18/20
+2.24 (+32.77%)
since 09/18/19

Most Recent Stories

More News
Eton Pharmaceuticals Provides Update on the FDA Review of EM-100

Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, reported that its partner has not yet received a communication...

ETON : 9.06 (+11.51%)
Eton Pharmaceuticals Announces Appointment of Ingrid Hoos as Senior Vice President of Scientific Affairs

Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today announced that it has appointed Ingrid Hoos as the...

ETON : 9.06 (+11.51%)
Eton Pharmaceuticals, Inc. (ETON) Reports Q2 Loss, Misses Revenue Estimates

Eton Pharmaceuticals, Inc. (ETON) delivered earnings and revenue surprises of 17.86% and -93.85%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?...

ETON : 9.06 (+11.51%)
Eton Pharmaceuticals Announces Second Quarter 2020 Financial Results

Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today reported financial results for the second quarter...

ETON : 9.06 (+11.51%)
Eton Pharmaceuticals Provides Update on the FDA Review of EM-100

Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, reported that its partner has not yet received a communication...

ETON : 9.06 (+11.51%)
Eton Pharmaceuticals to Report Second Quarter Financial Results on Wednesday, August 12, 2020

Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today announced that it will report second quarter 2020...

ETON : 9.06 (+11.51%)
Eton Pharmaceuticals, Inc. (ETON) Reports Q1 Loss, Lags Revenue Estimates

Eton Pharmaceuticals, Inc. (ETON) delivered earnings and revenue surprises of -108.33% and -93.89%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the...

ETON : 9.06 (+11.51%)
Eton Pharmaceuticals Announces First Quarter 2020 Financial Results

Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today reported financial results for the first quarter ended...

ETON : 9.06 (+11.51%)
Eton Pharmaceuticals Inc (ETON) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Eton Pharmaceuticals Inc (ETON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ETON : 9.06 (+11.51%)
Eton Pharmaceuticals to Report First Quarter Financial Results on Thursday, May 14, 2020

Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today announced that it will report first quarter 2020 financial...

ETON : 9.06 (+11.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Trade ETON with:

Business Summary

Eton Pharmaceuticals Inc. operates as a development stage biotechnology company. Its product pipeline consists of DS-300, EM-100, DS-100, DS-200, ET-103, ET-101, ET-102 and CT-100 which are in clinical stage. Eton Pharmaceuticals Inc. is based in Deer Park, Illinois.

See More

Key Turning Points

2nd Resistance Point 9.98
1st Resistance Point 9.52
Last Price 9.06
1st Support Level 8.20
2nd Support Level 7.34

See More

52-Week High 9.12
Last Price 9.06
Fibonacci 61.8% 6.59
Fibonacci 50% 5.81
Fibonacci 38.2% 5.03
52-Week Low 2.50

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar